Lip Enhancement Segment to Lead Global Dermal Fillers Market During 2023-2031

According to our new research study on "Dermal Fillers Market Forecast to 2031 - Global Analysis - by Product, Material, Application, End User, and Geography," the market is expected to grow from US$ 4.00 billion in 2023 to US$ 7.58 billion by 2031; it is estimated to record a CAGR of 8.3% from 2023-2031. Key factors driving the growth of the dermal fillers market are the increasing preference for minimally invasive procedures and the rising attraction of consumers toward beauty and wellness. However, the high cost of dermal filler procedures hinders the market's growth.

The requirement for personalized treatments, comprehensive results, and minimally invasive options results in a high preference for combination therapies. These therapies involve the use of multiple treatment modalities or products to achieve better results over a single therapy. Dermal fillers can be combined with botox, chemical peels, laser resurfacing, and microneedling. For instance, dermal fillers combined with botox have become a popular choice for facial rejuvenation, as this combination can effectively address various indications of aging. Dermal fillers enhance the skin, whereas botox relaxes the muscles that create wrinkles and lines. Together, they create a more complete metamorphosis, resulting in a smoother, more youthful appearance. The combined benefits are also longer-lasting than when the treatments are performed separately, as dermal fillers can aid in supporting botox's effects. Furthermore, combining dermal fillers and platelet-rich plasma (PRP) therapy helps stimulate the production of collagen and elastin proteins that are important for repairing skin. According to the Beautiful Orlando Medical Spa, combining PRP and dermal fillers, such as hyaluronic acid fillers, helps prolong longevity and enhances results. Dermal filler helps restore the skin areas that have lost volume over time. The addition of PRP helps in stimulating the body's regenerating mechanism. PRP can also cure skin conditions that fillers cannot, such as uneven texture and tones. Thus, the trend of combination therapies is expected to benefit the dermal fillers market performance by unlocking advantages such as high-quality results for skin with lower pain and recovery time. Thus, the growing adoption of combination therapies is likely to serve as a promising new trend in the dermal fillers market in the coming years.

Based on application, the dermal fillers market is segmented into facial line correction treatment, facelift, lip enhancement, scar treatment, and others. The lip enhancement segment held the largest dermal fillers market share in 2023, and it is expected to register the highest CAGR from 2023 to 2031. Lip enhancement includes a set of procedures that add or restore volume to the lips and smooth vertical lines surrounding the lips and mouth. Dermal fillers can be used to define the lip border, add volume to the lips, and correct asymmetry. Lip fillers are often made from hyaluronic acid as it helps retain moisture and create fullness. Lip enhancement with dermal fillers is an effective way to achieve plumper, more defined lips without the need for surgery. Compared to other surgical products, cost advantage will further promote the adoption in the review period. For instance, lip fillers may be under US$ 400, while other procedures, such as fat grafts, can range up to US$ 5,000.

North America accounted for the largest share of the global dermal fillers market in 2023. Europe is the second leading region in the market owing to consumers' high spending power and willingness to spend on cosmetic procedures. In addition, the high prevalence of skin disorders is a key factor driving the Europe dermal fillers market growth. Moreover, the rising demand for minimally invasive facial treatments in Europe is experiencing robust growth, with a plethora of opportunities to explore. A British Association of Aesthetic Plastic Surgeons 2019 report found that men now want to look "tweaked" rather than "tucked." Dr Johnson reported that the most popular treatments for men include Botox for wrinkles, dermal filler for jawline definition and chin enhancement, and a procedure called "facetite" that reduces double chins.

In 2023, Germany held the largest share of the dermal fillers market in the region. Growth in skin care is based on increasing purchasing frequency, the steady expansion of the major national and regional players, as well as higher spending per household. Rising attention and concerns about appearance contributes to the strong growth of the market. According to the International Society of Aesthetic Plastic Surgery, the highest number of injectable cosmetic procedures was performed in Germany in 2017, with more than 364,000. Total facial rejuvenation procedures were second highest in Germany, followed by Italy in Europe, with more than 26,000 procedures. The country had the tenth-highest number of cosmetic surgeons globally in 2017, with 1,129 plastic surgeons.

Merz Pharmaceuticals GmbH is one of the major German companies working in the dermal filler market. The company has launched several new products and expanded throughout the country in order to cater to customers' needs and improve its product portfolio. In September 2019, the company started a new dermal filler manufacturing site in Dessau with an investment of more than US$ 16 million in order to expand its presence in BioPharmaPark. Hyaluronic acid dermal fillers will be the major product produced in the new production plant from the company's Belotero product range. Further, AMALIAN offers a novel portfolio of 11 monophasic and biphasic hyaluronic acid fillers with different concentrations for treating fine to deep wrinkles, facial contouring, lip augmentation, and the treatment of scars. The innovative AMALIAN biphasic expert products are developed with a special core-in-shell technology that makes them easy to inject, disregarding their high structural viscosity, while the volume effect is quickly restored in the skin. AMALIAN dermal fillers are manufactured in Germany and underlie strict quality control. Thus, the abovementioned factors support the dermal fillers market growth in the region.

AbbVie Inc, Galderma SA, Merz Pharma GmbH & Co KGaA, Suneva Medical, Bioxis Pharmaceuticals, Bioplus Co. Ltd., Teoxane Laboratories, Bioha Laboratories, Prollenium Medical Technologies, and Sinclair Pharma Ltd are among the leading companies profiled in the dermal fillers market report.

Dermal Fillers Market, by Region, 2023 (%)

Source: The Insight Partners Analysis

Based on product, the dermal fillers market is bifurcated into biodegradable and nonbiodegradable. In terms of material, the market is classified into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate, fat fillers, and others. Based on application, the market is categorized into facial line correction treatment, lip enhancement, facelift, scar treatment, and others. Based on end user, the market is segmented into multispecialty hospitals, dermatology clinics, ambulatory surgical centers, and others. Based on geography, the dermal fillers market is categorized into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).


Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com